サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1421676

乳房病変局在化市場、シェア、市場規模、動向、産業分析レポート：タイプ別、用途別、エンドユーザー別、地域別、セグメント別予測、2023～2032年

Breast Lesion Localization Market Share, Size, Trends, Industry Analysis Report, By Type (Wire, Radioisotope, Magnetic, Electromagnetic Localization); By Usage; By End User; By Region; Segment Forecast, 2023- 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
乳房病変局在化市場、シェア、市場規模、動向、産業分析レポート：タイプ別、用途別、エンドユーザー別、地域別、セグメント別予測、2023～2032年
出版日: 2023年11月23日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Researchの最新調査によると、世界の乳房病変局在化市場規模は2032年までに5億4,674万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

乳房病変局在化に関する継続的な研究活動により、世界市場における最新技術に関する外科医の意識が高まっています。2022年にScience Directに掲載された研究では、術前の乳房＆腋窩局在の分析に焦点が当てられています。彼らはアンケートを作成し、乳房画像診断医学会に配布しました。その結果、学会と放射性シードの使用との間に相関関係があることが判明しました。マンモグラフィを読影する放射線科医の割合が多いクリニックでは、ワイヤレス定位装置がより普及していました。

クリニックにおけるフェローシップ研修を受けた乳腺放射線科医の数は、乳房病変の局在化に使用される方法と有意に正の相関があった。この研究により、クリニックのタイプによって乳房と腋窩病変の局在化技術が異なることが明らかになった。ワイヤレス局在化装置は学術的な環境で使用される可能性が高く、最新の局在化技術の使用を統合することは、小規模で専門性の低いクリニックにとって課題となる可能性があることがわかった。このことは、さまざまな状態に対するさまざまな技術の応用に関するさらなる調査活動を促進し、医師が患者の特定の健康状態に効果的なツールを選択するのに役立つ可能性があります。

2023年にPubMed Centralで発表された研究では、触知不能な乳房病変の治療において外科医が使用する局在化技術の系統的レビューに焦点が当てられています。その中で最もポピュラーな方法は、ワイヤーガイド下定位法（WGL）です。過去20年の間に、結果とロジスティクスの向上を目標に、他の方法（放射性、磁気、レーダーまたは高周波、術中超音波）が開発されました。しかし、外科医や放射線科医がこれらの方法についてどのように感じているかについてはほとんど知られていないため、さまざまな局在化技術に対する外科医の嗜好に関する将来の研究活動の展望が広がっています。研究活動の高まりは、今後数年間における乳房病変局在化市場の成長の可能性を生み出すと思われます。

乳房病変局在化市場レポートハイライト

  • 電磁法セグメントは、その高い有効性により、今後数年間で最も高い成長が見込まれます。
  • 乳房の外観に関する懸念の高まりにより、乳房温存分野が最大の市場シェアを占める。
  • 外来手術センターセグメントは、その採用拡大により、より大きな収益シェアを占めると予測されます。
  • 北米は、乳がん撲滅に向けた政府のイニシアチブの高まりにより、調査期間中に最大の成長率を記録すると予測されています。
  • アジア太平洋は、乳がんの有病率の上昇により、最も速い成長が見込まれています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の乳房病変局在化市場別洞察

  • 乳房病変局在化市場-エンドユーザーのスナップショット
  • 乳房病変局在化市場力学
    • 促進要因と機会
      • 高齢化人口の増加
      • 乳がんの発生率の増加
    • 抑制要因と課題
      • 発展途上地域におけるアクセス制限
  • PESTEL分析
  • 乳房病変局在化市場のエンドユーザーの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の乳房病変局在化市場、タイプ別

  • 主要調査結果
  • イントロダクション
  • ワイヤー局在化
  • 放射性同位元素局在化
  • 磁気局在化
  • 電磁局在化
  • その他

第6章 世界の乳房病変局在化市場、用途別

  • 主要調査結果
  • イントロダクション
  • 乳房生検
  • 乳房温存（乳房切除術）

第7章 世界の乳房病変局在化市場、エンドユーザー別

  • 主要調査結果
  • イントロダクション
  • 病院とクリニック
  • 画像診断センター
  • 外来手術センター
  • その他

第8章 世界の乳房病変局在化市場、地域別

  • 主要調査結果
  • イントロダクション
    • 乳房病変局在化市場評価、地域別、2019～2032年
  • 乳房病変局在化市場-北米
    • 北米：乳房病変局在化市場、タイプ別、2019～2032年
    • 北米：乳房病変局在化市場、エンドユーザー別、2019～2032年
    • 北米：乳房病変局在化市場、用途別、2019～2032年
    • 乳房病変局在化市場-米国
    • 乳房病変局在化市場-カナダ
  • 乳房病変局在化市場-欧州
    • 欧州：乳房病変局在化市場、タイプ別、2019～2032年
    • 欧州：乳房病変局在化市場、エンドユーザー別、2019～2032年
    • 欧州：乳房病変局在化市場、用途別、2019～2032年
    • 乳房病変局在化市場-英国
    • 乳房病変局在化市場-フランス
    • 乳房病変局在化市場-ドイツ
    • 乳房病変局在化市場-イタリア
    • 乳房病変局在化市場-スペイン
    • 乳房病変局在化市場-オランダ
    • 乳房病変局在化市場-ロシア
  • 乳房病変局在化市場-アジア太平洋
    • アジア太平洋：乳房病変局在化市場、タイプ別、2019～2032年
    • アジア太平洋：乳房病変局在化市場、エンドユーザー別、2019～2032年
    • アジア太平洋：乳房病変局在化市場、用途別、2019～2032年
    • 乳房病変局在化市場-中国
    • 乳房病変局在化市場-インド
    • 乳房病変局在化市場-マレーシア
    • 乳房病変局在化市場-日本
    • 乳房病変局在化市場-インドネシア
    • 乳房病変局在化市場-韓国
  • 乳房病変局在化市場-中東・アフリカ
    • 中東・アフリカ：乳房病変局在化市場、タイプ別、2019～2032年
    • 中東・アフリカ：乳房病変局在化市場、エンドユーザー別、2019～2032年
    • 中東・アフリカ：乳房病変局在化市場、用途別、2019～2032年
    • 乳房病変局在化市場-サウジアラビア
    • 乳房病変局在化市場-アラブ首長国連邦
    • 乳房病変局在化市場-イスラエル
    • 乳房病変局在化市場-南アフリカ
  • 乳房病変局在化市場-ラテンアメリカ
    • ラテンアメリカ：乳房病変局在化市場、タイプ別、2019～2032年
    • ラテンアメリカ：乳房病変局在化市場、エンドユーザー別、2019～2032年
    • ラテンアメリカ：乳房病変局在化市場、用途別、2019～2032年
    • 乳房病変局在化市場-メキシコ
    • 乳房病変局在化市場-ブラジル
    • 乳房病変局在化市場-アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Ambu
  • ARGON MEDICAL
  • Biomedical Srl
  • BPB Medica
  • Dragerwerk
  • Elucent Medical
  • Endomagnetics
  • GE Healthcare
  • Hologic
  • Intramedical Imaging
  • Isoaid
  • Izi Medical Products
  • Koninklijke Philips
  • Laurane Medical
  • MatekMedikal
  • MDL SRL
図表

List of Tables

  • Table 1 Global Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 3 Global Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 4 Breast Lesion Localization Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 6 North America: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 7 North America: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 10 U.S.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 12 Canada: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 13 Canada: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 15 Europe: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 16 Europe: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 18 UK: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 19 UK: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 21 France: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 22 France: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 24 Germany: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 25 Germany: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 27 Italy: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 28 Italy: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 30 Spain: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 31 Spain: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 34 Netherlands: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 36 Russia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 37 Russia: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 42 China: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 43 China: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 45 India: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 46 India: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 49 Malaysia: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 51 Japan: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 52 Japan: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 55 Indonesia: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 58 South Korea: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 66 UAE: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 67 UAE: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 69 Israel: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 70 Israel: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 73 South Africa: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 76 Latin America: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 79 Mexico: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 82 Brazil: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • Table 85 Argentina: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Breast Lesion Localization Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Usage
  • Figure 7. Global Breast Lesion Localization Market, by Usage, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Breast Lesion Localization Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Breast Lesion Localization Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Breast Lesion Localization Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Breast Lesion Localization Market
目次
Product Code: PM4015

The global breast lesion localization market size is expected to reach USD 546.74 million by 2032, according to a new study by Polaris Market Research. The report "Breast Lesion Localization Market Share, Size, Trends, Industry Analysis Report, By Type (Wire, Radioisotope, Magnetic, Electromagnetic Localization); By Usage; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The ongoing research activities on breast lesion localization are creating awareness among surgeons about the latest technologies in the global market. A study published in Science Direct in 2022 focused on the analysis of pre-operative breast & axillary localizations. They prepared a questionnaire and circulated it to the Society of Breast Imaging Physicians. They witnessed a correlation between academics and the use of radioactive seeds. Wireless localization devices were more prevalent in practices, with a larger proportion of radiologists who read mammography.

The number of breast radiologists with fellowship training in a practice was significantly correlated positively with the methods used to localize breast lesions. This study reveals that different practice types use different localization techniques for breast and axillary lesions. They found that wireless localization devices are more likely to be used in academic settings, and integrating the use of modern localization techniques may provide challenges for smaller and less specialised practices. This facilitates further research activities on the applications of different technologies to various conditions, which may assist doctors in choosing effective tools for particular health conditions for their patients.

A study published in 2023 in PubMed Central focused on a systematic review of the localization technologies used by surgeons in treating non-palpable breast lesions. The most popular method out of those that are available is wire-guided localization (WGL). In the past twenty years, other methods (radioactive, magnetic, radar- or radiofrequency-based, and intraoperative ultrasound) have been developed with the goal of enhancing results and logistics. The study concluded that wire-free localization is preferred by patients more often, according to smaller research, but little is known about how surgeons and radiologists feel about these methods, facilitating a scope for future research activities on surgeon preferences towards various localization technologies. The rising research activities will create growth potential for the breast lesion localization market in the coming years.

Breast Lesion Localization Market Report Highlights

  • Electromagnetic segment is anticipated to witness the highest growth in the coming years due to its higher effectiveness.
  • Breast Conservation segment accounted for the largest market share owing to rising concerns about breast appearance.
  • Ambulatory surgical center segment is projected to experience a larger revenue share due to its growing adoption.
  • North America is projected to register a largest growth rate in the study period owing to the growing government initiatives to eliminate breast cancer.
  • Asia Pacific is expected to have the fastest growth owing to the rising prevalence of breast cancer.
  • The global players include: Ambu, ARGON MEDICAL, Biomedical Srl, BPB Medica, Dragerwerk, Intramedical Imaging, Isoaid, Izi Medical Products & Koninklijke Philips.

Polaris Market Research has segmented the breast lesion localization market report based on type, usage, end user and region:

Breast Lesion Localization, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Wire Localization
  • Radioisotope Localization
  • Radioguided Occult Lesion Localization (ROLL)
  • Radioactive Seed Localization (RSL)
  • Magnetic Localization
  • Electromagnetic Localization
  • Other Localization Methods

Breast Lesion Localization, Usage Outlook (Revenue - USD Million, 2019 - 2032)

  • Breast Biopsy
  • Breast Conservation (Lumpectomy)

Breast Lesion Localization, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals & Clinics
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Breast Lesion Localization, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Breast Lesion Localization Market Insights

  • 4.1. Breast Lesion Localization Market - End User Snapshot
  • 4.2. Breast Lesion Localization Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing aging population
      • 4.2.1.2. Rising Incidence of Breast Cancer
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Access in Developing Regions
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Breast Lesion Localization Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Breast Lesion Localization Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
  • 5.3. Wire Localization
    • 5.3.1. Global Breast Lesion Localization Market, by Wire Localization, by Region, 2019-2032 (USD Million)
  • 5.4. Radioisotope Localization
    • 5.4.1. Global Breast Lesion Localization Market, by Radioisotope Localization, by Region, 2019-2032 (USD Million)
  • 5.5. Magnetic Localization
    • 5.5.1. Global Breast Lesion Localization Market, by Magnetic Localization, by Region, 2019-2032 (USD Million)
  • 5.6. Electromagnetic Localization
    • 5.6.1. Global Breast Lesion Localization Market, by Electromagnetic Localization, by Region, 2019-2032 (USD Million)
  • 5.7. Other Localization Methods
    • 5.7.1. Global Breast Lesion Localization Market, by Other Localization Methods, by Region, 2019-2032 (USD Million)

6. Global Breast Lesion Localization Market, by Usage

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • 6.3. Breast Biopsy
    • 6.3.1. Global Breast Lesion Localization Market, by Breast Biopsy, by Region, 2019-2032 (USD Million)
  • 6.4. Breast Conservation (Lumpectomy)
    • 6.4.1. Global Breast Lesion Localization Market, by Breast Conservation (Lumpectomy), by Region, 2019-2032 (USD Million)

7. Global Breast Lesion Localization Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Breast Lesion Localization Market, by Hospitals & Clinics, By Region, 2019-2032 (USD Million)
  • 7.4. Diagnostic Imaging Centers
    • 7.4.1. Global Breast Lesion Localization Market, by Diagnostic Imaging Centers, By Region, 2019-2032 (USD Million)
  • 7.5. Ambulatory Surgical Centers
    • 7.5.1. Global Breast Lesion Localization Market, by Ambulatory Surgical Centers, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Breast Lesion Localization Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Breast Lesion Localization Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Breast Lesion Localization Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Breast Lesion Localization Market - North America
    • 8.3.1. North America: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.3.4. Breast Lesion Localization Market - U.S.
      • 8.3.4.1. U.S.: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.3.5. Breast Lesion Localization Market - Canada
      • 8.3.5.1. Canada: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • 8.4. Breast Lesion Localization Market - Europe
    • 8.4.1. Europe: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.4.4. Breast Lesion Localization Market - UK
      • 8.4.4.1. UK: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.4.5. Breast Lesion Localization Market - France
      • 8.4.5.1. France: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.4.6. Breast Lesion Localization Market - Germany
      • 8.4.6.1. Germany: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.4.7. Breast Lesion Localization Market - Italy
      • 8.4.7.1. Italy: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.4.8. Breast Lesion Localization Market - Spain
      • 8.4.8.1. Spain: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.4.9. Breast Lesion Localization Market - Netherlands
      • 8.4.9.1. Netherlands: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.4.10. Breast Lesion Localization Market - Russia
      • 8.4.10.1. Russia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • 8.5. Breast Lesion Localization Market - Asia Pacific
    • 8.5.1. Asia Pacific: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.5.4. Breast Lesion Localization Market - China
      • 8.5.4.1. China: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.5.5. Breast Lesion Localization Market - India
      • 8.5.5.1. India: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.5.6. Breast Lesion Localization Market - Malaysia
      • 8.5.6.1. Malaysia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.5.7. Breast Lesion Localization Market - Japan
      • 8.5.7.1. Japan: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.5.8. Breast Lesion Localization Market - Indonesia
      • 8.5.8.1. Indonesia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.5.9. Breast Lesion Localization Market - South Korea
      • 8.5.9.1. South Korea: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • 8.6. Breast Lesion Localization Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.6.4. Breast Lesion Localization Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.6.5. Breast Lesion Localization Market - UAE
      • 8.6.5.1. UAE: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.6.6. Breast Lesion Localization Market - Israel
      • 8.6.6.1. Israel: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.6.7. Breast Lesion Localization Market - South Africa
      • 8.6.7.1. South Africa: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
  • 8.7. Breast Lesion Localization Market - Latin America
    • 8.7.1. Latin America: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.7.4. Breast Lesion Localization Market - Mexico
      • 8.7.4.1. Mexico: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.7.5. Breast Lesion Localization Market - Brazil
      • 8.7.5.1. Brazil: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)
    • 8.7.6. Breast Lesion Localization Market - Argentina
      • 8.7.6.1. Argentina: Breast Lesion Localization Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Breast Lesion Localization Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Breast Lesion Localization Market, by Usage, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Ambu
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. ARGON MEDICAL
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biomedical Srl
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. BPB Medica
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dragerwerk
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Elucent Medical
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Endomagnetics
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GE Healthcare
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Hologic
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Intramedical Imaging
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Isoaid
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Izi Medical Products
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Koninklijke Philips
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Laurane Medical
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. MatekMedikal
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. MDL SRL
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development